CCN4 and breast carcinoma: Consistent with this finding, the level of WISP1 expression was much lower in metastatic breast cancer compared to nonmetastatic breast cancer, suggesting that WISP1 may serve as an indicator of the risk of metastasis in breast carcinoma [10].